|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents: | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in other financial institutions | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Held-to-maturity debt securities, net of allowance for credit losses of $71 and $71 (fair value of $93,979 and $68,161), respectively | ||||||||||||||||||||
| Available-for-sale debt securities, at fair value (amortized cost of $89,745 and $45,623, respectively) | ||||||||||||||||||||
| Held-to-maturity debt securities, net of allowance for credit losses of $151 and $74 (fair value of $112,617 and $90,635), respectively | ||||||||||||||||||||
| Correspondent bank stock, at cost | ||||||||||||||||||||
| Mortgage loans held for sale, at fair value | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Loans (includes $4,208 and $7,283 measured at fair value, respectively) | ||||||||||||||||||||
| Loans (includes $1,758 and $3,182 measured at fair value, respectively) | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Total, net | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Other real estate owned, net | ||||||||||||||||||||
| Goodwill and other intangible assets, net | ||||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||||
| Company-owned life insurance | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||||
| Interest-bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Borrowings: | ||||||||||||||||||||
| Federal Home Loan Bank and Federal Reserve borrowings | ||||||||||||||||||||
| Subordinated notes | ||||||||||||||||||||
| Accrued interest payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' Equity | ||||||||||||||||||||
| Preferred stock - no par value; 10,000,000 shares authorized; 0 issued and outstanding | ||||||||||||||||||||
| Common stock - no par value; 90,000,000 shares authorized; 9,765,129 and 9,725,731 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
